Background

• Multiple myeloma patients’ survival is improved by autologous haematopoietic stem cell transplantation (ASCT).
• ASCT first consists of collecting from the patient an optimal number of healthy haematopoietic stem and progenitor cells (HSPCs) expressing the marker CD34.
• These healthy stem cells are stored and re-infused after the patient is exposed...